Due to Pfizer’s underperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautious about the stock’s prospects

Taylor Morrison Home has been treading water for the past six months, recording a small loss of 1.6% while holding steady at $66.89. The stock also fell short of the S&P 500’s 6.2% gain during that period.

Futures on the major gauges dip ahead of a highly anticipated State of Union address by the president.

Holding company and industrial conglomerate Icahn (NYSE:IEP) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.2% year on year to $2.7 billion. Its GAAP loss of $0 per share was significantly below analysts’ consensus

Safety and security company Federal Signal (NYSE:FSS) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 26.5% year on year to $597.1 million. The company’s full-year revenue guidance of $2.6 billion at the midpoint came in 5

Sally Beauty has had an impressive run over the past six months as its shares have beaten the S&P 500 by 14.6%. The stock now trades at $16.32, marking a 20.8% gain. This run-up might have investors contemplating their next move.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Aflac (NYSE:AFL) and the rest of the life insurance stocks fared in Q4.

Although Amgen has outpaced the Dow over the past year, analysts remain cautiously optimistic about the stock’s prospects.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the auto parts retailer industry, including O'Reilly (NASDAQ:ORLY) and its peers.

HSBC is handing its best bankers bigger bonuses as it seeks to compete with Wall Street rivals.

Food and beverage supplier MGP Ingredients (NASDAQ:MGPI) announced better-than-expected revenue in Q4 CY2025, but sales fell by 23.5% year on year to $138.3 million. On the other hand, the company’s full-year revenue guidance of $490 million at the midpoi

NIKE has underperformed the S&P 500 over the past year, and analysts remain cautiously optimistic about the stock’s growth potential.

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths

Behavioral health company Acadia Healthcare (NASDAQ:ACHC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.1% year on year to $821.5 million. Guidance for next quarter’s revenue was optimistic at $825 million at the m

Cisco Systems has outpaced the Dow Jones Industrial Average over the past year, and analysts remain only cautiously optimistic on its outlook.